首页 > 最新文献

Journal of Nutrition最新文献

英文 中文
Eating Egg-Rich Diets and Modeling the Addition of One Daily Egg Reduced Risk of Nutrient Inadequacy among United States Adolescents with and without Food Insecurity 食用富含鸡蛋的膳食和建立每天添加一个鸡蛋的模型可降低美国青少年营养不足的风险,无论他们是否存在粮食不安全问题。
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.09.019
Analí Morales-Juárez , Alexandra E Cowan-Pyle , Regan L Bailey , Heather A Eicher-Miller

Background

Adolescents have the poorest dietary intake throughout their lifespan. Food insecurity worsens these nutritional risks. Eggs are a nutrient-dense strategy to increase nutrient quality.

Objectives

1) compare usual nutrient intakes, Dietary Reference Intake and protein compliance with recommendations and scores of micronutrient quality; and 2) analyze how adding 1 egg affects adolescents’ nutrient profiles, by food security status and egg-rich diets.

Methods

Dietary data of United States adolescents in the 2007–2018 National Health and Nutrition Examination Survey were analyzed (14–17 y; n = 3633). Egg-rich diet levels were categorized as 1) no eggs, 2) eggs as ingredients in dishes, or 3) primarily egg dishes. Food security status was classified using the United States Household Food Security Survey Module. The National Cancer Institute method was used to estimate usual nutrient intake and nutrient exposure scores [i.e., Food Nutrient Index (FNI) and Total Nutrient Index (TNI)]. Nutrient amounts from 1 medium egg were modeled on existing intakes. Pairwise t-tests determined significant differences.

Results

Over 60% of adolescents risked inadequate intake of calcium, choline, magnesium, vitamin D, and vitamin E regardless of food security status. Food-secure adolescents consuming primarily egg dishes had higher mean usual intakes of lutein + zeaxanthin (1544.1 μg), choline (408.4 mg), vitamin B2 (2.3 mg), selenium (128.6 μg), vitamin D (6 μg), docosahexaenoic acid (70 mg), and protein (89.1 g) than other groups (P < 0.0002). Those who were food secure and consuming eggs as ingredients in dishes demonstrated higher nutrient adequacy for magnesium (scored ∼66 out of 100), potassium (scored 81), and total scores (scored 72 and 69, respectively) for the TNI and FNI; and folate only (scored 92) for the TNI, than those who were food insecure and not consuming eggs (P < 0.0002). Adding 1 egg increased choline and vitamin D usual intakes for some groups and nutrient index scores for all groups (P < 0.0005).

Conclusions

Adolescents are at substantial nutritional risk that was exacerbated by food insecurity and less egg consumption.
背景:在人的一生中,青少年的膳食摄入量最差。粮食不安全加剧了这些营养风险。目标:1)比较通常营养素摄入量、膳食营养素参考摄入量和蛋白质摄入量是否符合建议,以及微量营养素质量评分;2)根据食品安全状况和富含鸡蛋的膳食,分析增加一个鸡蛋对青少年营养概况的影响:方法:分析了 2007-2018 年 NHANES 中美国青少年的膳食数据(14-17 岁;n=3,633)。富含鸡蛋的饮食水平分为:1)非鸡蛋;2)作为菜肴配料的鸡蛋;或 3)以鸡蛋为主的菜肴。食品安全状况采用美国家庭食品安全调查模块进行分类。采用美国国家癌症研究所的方法估算通常的营养素摄入量和营养素暴露分数(即食物营养素指数和总营养素指数)。一个中等大小鸡蛋中的营养素含量以现有摄入量为模型。配对 t 检验确定显著差异:结果:无论食品安全状况如何,60%以上的青少年有可能摄入钙、胆碱、镁、维生素 D 和 E 不足。食品安全青少年主要食用蛋类菜肴,其叶黄素+玉米黄质(1544.1微克)、胆碱(408.4毫克)、维生素B2(2.3毫克)、硒(128.6微克)、维生素D(6微克)、二十二碳六烯酸(70毫克)和蛋白质(89.1克)的平均平时摄入量高于其他组别(结论:食品安全青少年的营养摄入量不足,可能会对他们的健康造成严重影响:青少年面临着巨大的营养风险,而粮食不安全和食用鸡蛋较少又加剧了这一风险。
{"title":"Eating Egg-Rich Diets and Modeling the Addition of One Daily Egg Reduced Risk of Nutrient Inadequacy among United States Adolescents with and without Food Insecurity","authors":"Analí Morales-Juárez ,&nbsp;Alexandra E Cowan-Pyle ,&nbsp;Regan L Bailey ,&nbsp;Heather A Eicher-Miller","doi":"10.1016/j.tjnut.2024.09.019","DOIUrl":"10.1016/j.tjnut.2024.09.019","url":null,"abstract":"<div><h3>Background</h3><div>Adolescents have the poorest dietary intake throughout their lifespan. Food insecurity worsens these nutritional risks. Eggs are a nutrient-dense strategy to increase nutrient quality.</div></div><div><h3>Objectives</h3><div><em>1</em>) compare usual nutrient intakes, Dietary Reference Intake and protein compliance with recommendations and scores of micronutrient quality; and <em>2</em>) analyze how adding 1 egg affects adolescents’ nutrient profiles, by food security status and egg-rich diets.</div></div><div><h3>Methods</h3><div>Dietary data of United States adolescents in the 2007–2018 National Health and Nutrition Examination Survey were analyzed (14–17 y; <em>n</em> = 3633). Egg-rich diet levels were categorized as <em>1</em>) no eggs, <em>2</em>) eggs as ingredients in dishes, or <em>3</em>) primarily egg dishes. Food security status was classified using the United States Household Food Security Survey Module. The National Cancer Institute method was used to estimate usual nutrient intake and nutrient exposure scores [i.e., Food Nutrient Index (FNI) and Total Nutrient Index (TNI)]. Nutrient amounts from 1 medium egg were modeled on existing intakes. Pairwise t-tests determined significant differences.</div></div><div><h3>Results</h3><div>Over 60% of adolescents risked inadequate intake of calcium, choline, magnesium, vitamin D, and vitamin E regardless of food security status. Food-secure adolescents consuming primarily egg dishes had higher mean usual intakes of lutein + zeaxanthin (1544.1 <em>μ</em>g), choline (408.4 mg), vitamin B2 (2.3 mg), selenium (128.6 <em>μ</em>g), vitamin D (6 <em>μ</em>g), docosahexaenoic acid (70 mg), and protein (89.1 g) than other groups (<em>P</em> &lt; 0.0002). Those who were food secure and consuming eggs as ingredients in dishes demonstrated higher nutrient adequacy for magnesium (scored ∼66 out of 100), potassium (scored 81), and total scores (scored 72 and 69, respectively) for the TNI and FNI; and folate only (scored 92) for the TNI, than those who were food insecure and not consuming eggs (<em>P</em> &lt; 0.0002). Adding 1 egg increased choline and vitamin D usual intakes for some groups and nutrient index scores for all groups (<em>P</em> &lt; 0.0005).</div></div><div><h3>Conclusions</h3><div>Adolescents are at substantial nutritional risk that was exacerbated by food insecurity and less egg consumption.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3475-3484"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intake of Added Sugar from Different Sources and Risk of All-Cause Mortality and Cardiovascular Diseases: The Role of Body Mass Index 不同来源的添加糖摄入量与全因死亡率和心血管疾病风险:身体质量指数的作用
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.09.017
Ziwei Shi , Wenmin Zhu , Zhiqun Lei , Xiaolong Yan , Xinyue Zhang , Sheng Wei , Qi Wang

Background

Recent studies have shown an ascending trend in global added sugar consumption. Evidence for the long-term consequences of added sugar from different sources on all-cause mortality and cardiovascular diseases (CVDs) remains limited.

Objectives

This study aimed to examine the associations between added sugar from various sources and the risk of all-cause mortality and CVDs, and to determine whether genetic predisposition and body mass index (BMI, in kg/m2) influence or mediate these associations.

Methods

We included 196,414 UK Biobank participants who completed a 24-h food survey between 2009 and 2012. Sugar contents were collected from the Composition of Foods Integrated Data set (CoFID). The National Death Registries and hospital records provided data on death and the disease diagnosis. We employed a polygenic risk score (PRS) to assess the genetic predisposition. Cox proportional hazards regression was used to analyze the associations.

Results

Totally, 10,081 deaths, 38,563 hypertension cases, 12,306 ischemic heart diseases (IHD), and 5491 cerebrovascular diseases were documented. Compared with the lowest quartile group of added sugar intake, the hazard ratios for all-cause mortality in the highest quartile were 1.21 (95% CI: 1.14, 1.30) for total added sugar, 1.03 (95% CI: 0.97, 1.10) for solids, and 1.16 (95% CI: 1.10, 1.23) for beverages. For CVDs, significant associations were observed in total added sugar and beverage sources. These associations were not altered by PRS, and individuals at greatest risk showed higher PRS along with excessive added sugar consumption (Ptrend < 0.001). BMI was found to mediate the highest proportion of the association between added sugar and hypertension (19.10% for total; 36.95% for beverages).

Conclusions

Higher intake of added sugar, especially from beverages, is associated with an increased risk of all-cause mortality and CVDs. BMI mediates a proportion of these associations.
背景:最近的研究表明,全球添加糖的消费量呈上升趋势。关于不同来源的添加糖对全因死亡率和心血管疾病(CVDs)的长期影响的证据仍然有限:本研究旨在探讨各种来源的添加糖与全因死亡率和心血管疾病风险之间的关联,并确定遗传易感性和体重指数(BMI)是否会影响或调节这些关联:我们纳入了 196,414 名在 2009 年至 2012 年间完成 24 小时食物调查的英国生物库参与者。糖含量是从食品成分综合数据集(CoFID)中收集的。国家死亡登记和医院记录提供了死亡和疾病诊断数据。我们采用多基因风险评分(PRS)来评估遗传易感性。我们采用了多基因风险评分(PRS)来评估遗传易感性,并使用 Cox 比例危险回归来分析相关性:共记录了 10,081 例死亡、38,563 例高血压、12,306 例缺血性心脏病和 5,491 例脑血管疾病。与添加糖摄入量最低的四分位组相比,添加糖摄入量最高的四分位组的全因死亡率危险比分别为:总添加糖 1.21(95% CI:1.14,1.30),固体 1.03(95% CI:0.97,1.10),饮料 1.16(95% CI:1.10,1.23)。就心血管疾病而言,在总添加糖和饮料来源中观察到了明显的相关性。这些关联并不因PRS而改变,风险最高的人群在摄入过多添加糖的同时,PRS也较高(Ptrend结论:较高的添加糖摄入量,尤其是饮料中的添加糖摄入量,与全因死亡率和心血管疾病风险的增加有关。体重指数在一定程度上调节了这些关联。
{"title":"Intake of Added Sugar from Different Sources and Risk of All-Cause Mortality and Cardiovascular Diseases: The Role of Body Mass Index","authors":"Ziwei Shi ,&nbsp;Wenmin Zhu ,&nbsp;Zhiqun Lei ,&nbsp;Xiaolong Yan ,&nbsp;Xinyue Zhang ,&nbsp;Sheng Wei ,&nbsp;Qi Wang","doi":"10.1016/j.tjnut.2024.09.017","DOIUrl":"10.1016/j.tjnut.2024.09.017","url":null,"abstract":"<div><h3>Background</h3><div>Recent studies have shown an ascending trend in global added sugar consumption. Evidence for the long-term consequences of added sugar from different sources on all-cause mortality and cardiovascular diseases (CVDs) remains limited.</div></div><div><h3>Objectives</h3><div>This study aimed to examine the associations between added sugar from various sources and the risk of all-cause mortality and CVDs, and to determine whether genetic predisposition and body mass index (BMI, in kg/m<sup>2</sup>) influence or mediate these associations.</div></div><div><h3>Methods</h3><div>We included 196,414 UK Biobank participants who completed a 24-h food survey between 2009 and 2012. Sugar contents were collected from the Composition of Foods Integrated Data set (CoFID). The National Death Registries and hospital records provided data on death and the disease diagnosis. We employed a polygenic risk score (PRS) to assess the genetic predisposition. Cox proportional hazards regression was used to analyze the associations.</div></div><div><h3>Results</h3><div>Totally, 10,081 deaths, 38,563 hypertension cases, 12,306 ischemic heart diseases (IHD), and 5491 cerebrovascular diseases were documented. Compared with the lowest quartile group of added sugar intake, the hazard ratios for all-cause mortality in the highest quartile were 1.21 (95% CI: 1.14, 1.30) for total added sugar, 1.03 (95% CI: 0.97, 1.10) for solids, and 1.16 (95% CI: 1.10, 1.23) for beverages. For CVDs, significant associations were observed in total added sugar and beverage sources. These associations were not altered by PRS, and individuals at greatest risk showed higher PRS along with excessive added sugar consumption (<em>P</em><sub>trend</sub> &lt; 0.001). BMI was found to mediate the highest proportion of the association between added sugar and hypertension (19.10% for total; 36.95% for beverages).</div></div><div><h3>Conclusions</h3><div>Higher intake of added sugar, especially from beverages, is associated with an increased risk of all-cause mortality and CVDs. BMI mediates a proportion of these associations.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3457-3464"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decoding Betaine: A Critical Analysis of Therapeutic Potential Compared with Marketing Hype—A Narrative Review 解码甜菜碱:治疗潜力与营销炒作的批判性分析--叙述性评论。
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.08.030
Grzegorz Nikrandt, Agata Chmurzynska
Research interest in betaine supplementation has surged in recent years, for both enhancing sports performance and treating metabolic conditions. This surge aligns with an expanding market for betaine supplements, which are often marketed as promising aids for a range of metabolic conditions. Despite numerous in vitro and in vivo studies elucidating betaine’s involvement in crucial metabolic pathways, consensus remains elusive on its clinical efficacy as a dietary supplement, based on results from randomized controlled trials. One analysis of dietary betaine intake in 28 observational studies showed a mean intake of 182 mg/d of betaine, with the main sources including grain-based foods, baked products, grains, cereals, and vegetables. Analysis of the results from human randomized clinical trials has shown that betaine supplementation improves body composition when combined with physical activity. Additionally, betaine supplementation decreases serum homocysteine levels, but does not affect liver enzymes, triglycerides, or high-density lipoprotein cholesterol levels, although it does increase total cholesterol and low-density lipoprotein cholesterol levels at doses ≥4 g/d. Market analysis has demonstrated that betaine is a popular supplement for supporting various physiological processes, such as digestibility, methylation, physical performance, and liver or cardiovascular health. Manufacturers suggest a diverse range of applications for betaine supplements, with 14 different uses identified. Additionally, high variability can be seen in the recommended usage directions for betaine. This narrative research sheds light on the evolving landscape of betaine supplementation and highlights the need for further investigation to clarify its clinical efficacy.
近年来,人们对甜菜碱补充剂的研究兴趣激增,这既是为了提高运动成绩,也是为了治疗代谢疾病。这种激增与甜菜碱补充剂市场的不断扩大相吻合,甜菜碱补充剂在市场上通常被当作治疗一系列代谢疾病的有效辅助剂。尽管大量体外和体内研究阐明了甜菜碱参与重要代谢途径的情况,但根据随机对照试验的结果,人们对其作为膳食补充剂的临床疗效仍未达成共识。一项对 28 项观察性研究中甜菜碱膳食摄入量的分析显示,甜菜碱的平均摄入量为 182 毫克/天,主要来源包括谷类食品、烘焙产品、谷物、谷类食品和蔬菜。对人类随机临床试验结果的分析表明,补充甜菜碱与体育锻炼相结合可改善身体组成。此外,补充甜菜碱可降低血清同型半胱氨酸(Hcy)水平,但不会影响肝酶、甘油三酯(TG)或高密度脂蛋白(HDL)胆固醇水平,不过当剂量≥4 克/天时,会增加总胆固醇(TC)和低密度脂蛋白(LDL)胆固醇水平。市场分析表明,甜菜碱是一种很受欢迎的补充剂,可用于支持各种生理过程,如消化、甲基化、体能、肝脏或心血管健康。生产商建议甜菜碱补充剂有多种用途,共确定了 14 种不同用途。此外,甜菜碱的推荐使用说明也存在很大差异。这项叙述性研究揭示了甜菜碱补充剂不断发展的现状,并强调了进一步调查以明确其临床疗效的必要性。
{"title":"Decoding Betaine: A Critical Analysis of Therapeutic Potential Compared with Marketing Hype—A Narrative Review","authors":"Grzegorz Nikrandt,&nbsp;Agata Chmurzynska","doi":"10.1016/j.tjnut.2024.08.030","DOIUrl":"10.1016/j.tjnut.2024.08.030","url":null,"abstract":"<div><div>Research interest in betaine supplementation has surged in recent years, for both enhancing sports performance and treating metabolic conditions. This surge aligns with an expanding market for betaine supplements, which are often marketed as promising aids for a range of metabolic conditions. Despite numerous in vitro and in vivo studies elucidating betaine’s involvement in crucial metabolic pathways, consensus remains elusive on its clinical efficacy as a dietary supplement, based on results from randomized controlled trials. One analysis of dietary betaine intake in 28 observational studies showed a mean intake of 182 mg/d of betaine, with the main sources including grain-based foods, baked products, grains, cereals, and vegetables. Analysis of the results from human randomized clinical trials has shown that betaine supplementation improves body composition when combined with physical activity. Additionally, betaine supplementation decreases serum homocysteine levels, but does not affect liver enzymes, triglycerides, or high-density lipoprotein cholesterol levels, although it does increase total cholesterol and low-density lipoprotein cholesterol levels at doses ≥4 g/d. Market analysis has demonstrated that betaine is a popular supplement for supporting various physiological processes, such as digestibility, methylation, physical performance, and liver or cardiovascular health. Manufacturers suggest a diverse range of applications for betaine supplements, with 14 different uses identified. Additionally, high variability can be seen in the recommended usage directions for betaine. This narrative research sheds light on the evolving landscape of betaine supplementation and highlights the need for further investigation to clarify its clinical efficacy.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3167-3176"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential One-Carbon Metabolites among Children with Autism Spectrum Disorder: A Case-Control Study 自闭症谱系障碍儿童的一碳代谢物差异:病例对照研究
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.09.004
Tianqi Wang , Wennan He , Yun Chen , Yuxun Gou , Yu Ma , Xiaonan Du , Yi Wang , Weili Yan , Hao Zhou

Background

Driven by the complex multifactorial etiopathogenesis of autism spectrum disorder (ASD), a growing interest surrounds the disturbance in folate-dependent one-carbon metabolism (OCM) in the pathology of ASD, whereas the evidence remained inconclusive.

Objectives

The study aims to investigate the association of OCM metabolism and ASD and characterize differential OCM metabolites among children with ASD.

Methods

Plasma OCM metabolites were investigated in 59 children with ASD and 40 neurotypical children using ultra-performance liquid chromatography tandem mass spectrometry technology. Differences (significance level < 0.001) were tested in each OCM metabolite between cases and controls. Multivariable models were also performed after adjusting for covariates.

Results

Ten out of 22 examined OCM metabolites were significantly different in children with ASD, compared with neurotypical controls. Specifically, S-adenosylmethionine (SAM), oxidized glutathione (GSSG), and glutathione (GSH) levels were increased, whereas S-adenosylhomocysteine (SAH), choline, glycine, L-serine, cystathionine, L-cysteine, and taurine levels were significantly decreased. Children with ASD showed significantly higher SAM/SAH ratio (3.87 ± 0.93 compared with 2.00 ± 0.76, P = 0.0001) and lower GSH/GSSG ratio [0.58 (0.46, 0.81) compared with 1.71 (0.93, 2.99)] compared with the neurotypical controls. Potential interactive effects between SAM/SAH ratio, taurine, L-serine, and gastrointestinal syndromes were further observed.

Conclusions

OCM disturbance was observed among children with ASD, particularly in methionine methylation and trans-sulfuration pathways. The findings add valuable insights into the mechanisms underlying ASD and the potential of ameliorating OCM as a promising therapeutic of ASD, which warrant further validation.
背景由于自闭症谱系障碍(ASD)的病因发病机制复杂多样,人们对自闭症谱系障碍病理中叶酸依赖性一碳代谢(OCM)紊乱的关注与日俱增,但相关证据仍无定论。方法采用超高效液相色谱串联质谱(UPLC-MS)技术,对 59 名 ASD 儿童和 40 名神经畸形儿童的血浆 OCM 代谢物进行研究。检测了病例和对照组之间每种 OCM 代谢物的差异(显著性水平< 0.001)。结果在所检测的 22 种 OCM 代谢物中,有 10 种在 ASD 儿童中与神经畸形对照组相比有显著差异。具体来说,S-腺苷蛋氨酸 (SAM)、氧化谷胱甘肽 (GSSG) 和谷胱甘肽 (GSH) 水平升高,而 S-腺苷高半胱氨酸 (SAH)、胆碱、甘氨酸、L-丝氨酸、胱硫醚、L-半胱氨酸和牛磺酸水平明显下降。与神经畸形对照组相比,ASD患儿的SAM/SAH比值(3.87±0.93 vs. 2.00±0.76,p=0.0001)明显升高,GSH/GSSG比值(0.58 (0.46, 0.81) vs. 1.71 (0.93, 2.99))明显降低。结论在 ASD 儿童中观察到了 OCM 干扰,尤其是在蛋氨酸甲基化和反式硫化途径中。这些发现为了解 ASD 的发病机制提供了有价值的见解,同时也发现了改善 OCM 作为 ASD 治疗方法的潜力,这值得进一步验证。
{"title":"Differential One-Carbon Metabolites among Children with Autism Spectrum Disorder: A Case-Control Study","authors":"Tianqi Wang ,&nbsp;Wennan He ,&nbsp;Yun Chen ,&nbsp;Yuxun Gou ,&nbsp;Yu Ma ,&nbsp;Xiaonan Du ,&nbsp;Yi Wang ,&nbsp;Weili Yan ,&nbsp;Hao Zhou","doi":"10.1016/j.tjnut.2024.09.004","DOIUrl":"10.1016/j.tjnut.2024.09.004","url":null,"abstract":"<div><h3>Background</h3><div>Driven by the complex multifactorial etiopathogenesis of autism spectrum disorder (ASD), a growing interest surrounds the disturbance in folate-dependent one-carbon metabolism (OCM) in the pathology of ASD, whereas the evidence remained inconclusive.</div></div><div><h3>Objectives</h3><div>The study aims to investigate the association of OCM metabolism and ASD and characterize differential OCM metabolites among children with ASD.</div></div><div><h3>Methods</h3><div>Plasma OCM metabolites were investigated in 59 children with ASD and 40 neurotypical children using ultra-performance liquid chromatography tandem mass spectrometry technology. Differences (significance level &lt; 0.001) were tested in each OCM metabolite between cases and controls. Multivariable models were also performed after adjusting for covariates.</div></div><div><h3>Results</h3><div>Ten out of 22 examined OCM metabolites were significantly different in children with ASD, compared with neurotypical controls. Specifically, S-adenosylmethionine (SAM), oxidized glutathione (GSSG), and glutathione (GSH) levels were increased, whereas S-adenosylhomocysteine (SAH), choline, glycine, L-serine, cystathionine, L-cysteine, and taurine levels were significantly decreased. Children with ASD showed significantly higher SAM/SAH ratio (3.87 ± 0.93 compared with 2.00 ± 0.76, <em>P</em> = 0.0001) and lower GSH/GSSG ratio [0.58 (0.46, 0.81) compared with 1.71 (0.93, 2.99)] compared with the neurotypical controls. Potential interactive effects between SAM/SAH ratio, taurine, L-serine, and gastrointestinal syndromes were further observed.</div></div><div><h3>Conclusions</h3><div>OCM disturbance was observed among children with ASD, particularly in methionine methylation and trans-sulfuration pathways. The findings add valuable insights into the mechanisms underlying ASD and the potential of ameliorating OCM as a promising therapeutic of ASD, which warrant further validation.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3346-3352"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary Sugar and Saturated Fat Consumption Associated with the Gastrointestinal Microbiome during Pregnancy 膳食中糖和饱和脂肪的摄入量与孕期胃肠道微生物组的变化有关。
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.09.016
Caitlin Dreisbach , Tonja Nansel , Shyamal Peddada , Wanda Nicholson , Anna Maria Siega-Riz

Background

Growing evidence supports changes in the gastrointestinal microbiome over the course of pregnancy may have an impact on the short- and long-term health of both the mother and the child.

Objective

Our objective was to explore the association of diet quality, as measured by the Healthy Eating Index (HEI), with the composition and gene ontology (GO) representation of microbial function in the maternal gastrointestinal microbiome during pregnancy.

Methods

We conducted a retrospective, observational analysis of n = 185 pregnant participants in the Pregnancy Eating Attributes Study. Maternal dietary intake was assessed in the first trimester using the automated self-administered 24-h recall method, from which the HEI 2015 was calculated. Rectal swabs were obtained in the second trimester and sequenced using the NovaSeq 6000 system shotgun platform. We used unsupervised clustering to identify microbial enterotypes representative of maternal taxa and GO functional term composition. Multivariable linear models were used to identify associations between taxa, functional terms, and food components while controlling for relevant covariates. Multinomial regression was then used to predict enterotype membership based on a participant’s HEI food component score.

Results

Those in the high diet quality tertile had a lower early pregnancy BMI [mean (M) = 23.48 kg/m2, SD = 3.38] compared with the middle (M = 27.35, SD = 6.01) and low (M = 27.49, SD = 6.99) diet quality tertiles (P < 0.01). There were no statistically significant associations between the HEI components or the total HEI score and the 4 alpha diversity measures. Differences in taxa and GO term enterotypes were found in participants with, but not limited to, a higher saturated fat component score (β = 1.35, P = 0.01), added sugar HEI component (β = 0.07, P < 0.001), and higher total dairy score (β = 1.58, P = 0.01).

Conclusions

Specific dietary components are associated with microbial composition and function in the second trimester of pregnancy. These findings provide a foundation for future testable hypotheses.
背景:越来越多的证据表明,孕期胃肠道微生物组的变化可能会对母婴的短期和长期健康产生影响:我们的目的是探讨健康饮食指数(Healthy Eating Index,HEI)衡量的饮食质量与孕期母体胃肠道微生物组中微生物功能的组成和基因本体(Gene Ontology,GO)表征之间的关联:我们对参加孕期饮食特征研究(PEAS)的 185 名孕妇进行了回顾性观察分析。在妊娠头三个月,使用自动自控 24 小时回顾法(ASA24)对孕妇的饮食摄入量进行评估,并据此计算出 2015 年健康饮食指数。我们在妊娠后三个月采集了直肠拭子,并使用 NovaSeq 6000 系统霰弹枪平台进行了测序。我们使用无监督聚类来识别代表母体类群和 GO 功能项组成的微生物肠型。在控制相关协变量的同时,我们使用多变量线性模型来确定类群、功能项和食物成分之间的关联。然后使用多项式回归法根据参与者的 HEI 食物成分得分预测肠型成员:结果:与中等(M=27.35,SD=6.01)和低(M=27.49,SD=6.99)饮食质量三等分组相比,高饮食质量三等分组的孕早期体重指数较低(平均[M]=23.48 kg/m2,SD=3.38)(p结论:特定饮食成分与孕早期乳腺癌的发生有关:特定的膳食成分与妊娠后三个月的微生物组成和功能有关。这些发现为今后提出可检验的假设奠定了基础。
{"title":"Dietary Sugar and Saturated Fat Consumption Associated with the Gastrointestinal Microbiome during Pregnancy","authors":"Caitlin Dreisbach ,&nbsp;Tonja Nansel ,&nbsp;Shyamal Peddada ,&nbsp;Wanda Nicholson ,&nbsp;Anna Maria Siega-Riz","doi":"10.1016/j.tjnut.2024.09.016","DOIUrl":"10.1016/j.tjnut.2024.09.016","url":null,"abstract":"<div><h3>Background</h3><div>Growing evidence supports changes in the gastrointestinal microbiome over the course of pregnancy may have an impact on the short- and long-term health of both the mother and the child.</div></div><div><h3>Objective</h3><div>Our objective was to explore the association of diet quality, as measured by the Healthy Eating Index (HEI), with the composition and gene ontology (GO) representation of microbial function in the maternal gastrointestinal microbiome during pregnancy.</div></div><div><h3>Methods</h3><div>We conducted a retrospective, observational analysis of <em>n =</em> 185 pregnant participants in the Pregnancy Eating Attributes Study. Maternal dietary intake was assessed in the first trimester using the automated self-administered 24-h recall method, from which the HEI 2015 was calculated. Rectal swabs were obtained in the second trimester and sequenced using the NovaSeq 6000 system shotgun platform. We used unsupervised clustering to identify microbial enterotypes representative of maternal taxa and GO functional term composition. Multivariable linear models were used to identify associations between taxa, functional terms, and food components while controlling for relevant covariates. Multinomial regression was then used to predict enterotype membership based on a participant’s HEI food component score.</div></div><div><h3>Results</h3><div>Those in the high diet quality tertile had a lower early pregnancy BMI [mean (<em>M</em>) = 23.48 kg/m<sup>2</sup>, SD = 3.38] compared with the middle (<em>M</em> = 27.35, SD = 6.01) and low (<em>M</em> = 27.49, SD = 6.99) diet quality tertiles (<em>P</em> &lt; 0.01). There were no statistically significant associations between the HEI components or the total HEI score and the 4 alpha diversity measures. Differences in taxa and GO term enterotypes were found in participants with, but not limited to, a higher saturated fat component score (<em>β</em> = 1.35, <em>P</em> = 0.01), added sugar HEI component (<em>β</em> = 0.07, <em>P</em> &lt; 0.001), and higher total dairy score (<em>β</em> = 1.58, <em>P</em> = 0.01).</div></div><div><h3>Conclusions</h3><div>Specific dietary components are associated with microbial composition and function in the second trimester of pregnancy. These findings provide a foundation for future testable hypotheses.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3246-3254"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alginate Oligosaccharides Enhance Gut Microbiota and Intestinal Barrier Function, Alleviating Host Damage Induced by Deoxynivalenol in Mice 海藻酸寡糖可增强肠道微生物群和肠道屏障功能,减轻脱氧雪腐镰刀菌烯醇对小鼠宿主造成的损伤。
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.09.031
Jinqiu Mi , Yaoyi Tong , Qiyue Zhang , Qingfeng Wang , Yanwei Wang , Yue Wang , Gang Lin , Qiugang Ma , Tiantian Li , Shimeng Huang

Background

Alginate oligosaccharides (AOS) exhibits notable effects in terms of anti-inflammatory, antibacterial, and antioxidant properties. Deoxynivalenol (DON) has the potential to trigger intestinal inflammation by upregulating pro-inflammatory cytokines and apoptosis, thereby compromising the integrity of the intestinal barrier function and perturbing the balance of the gut microbiota.

Objectives

We assessed the impact of AOS on mitigating DON-induced intestinal damage and systemic inflammation in mice.

Methods

After a 1-wk acclimatization period, the mice were divided into 4 groups. For 3 wk, the AOS and AOS + DON groups were gavaged daily with 200 μL of AOS [200 mg/kg body weight (BW)], whereas the CON and DON groups received an equivalent volume of sterile Phosphate-Buffered Saline (PBS). Subsequently, for 1 wk, the DON and AOS + DON groups received 100 μL of DON (4.8 mg/kg BW) daily, whereas the control (CON) and AOS groups continued receiving PBS.

Results

After administering DON via gavage to mice, there was a significant decrease (P < 0.05) in body weights compared with the CON group. Interestingly, AOS exhibited a tendency to mitigate this weight loss in the AOS + DON group. In the feces of mice treated with both AOS and DON, the concentration of DON significantly increased (P < 0.05) compared with the DON group alone. Histological analysis revealed that DON exposure caused increased intestinal damage, including shortened villi and eroded epithelial cells, which was ameliorated by presupplementation with AOS, alleviating harm to the intestinal barrier function. In both jejunum and colon tissues, DON exposure significantly reduced (P < 0.05) the expression of tight junction proteins (claudin and occludin in the colon) and the mucin protein mucin 2, compared with the CON group. Prophylactic administration of AOS alleviated these reductions, thereby improving the expression levels of these key proteins. Additionally, AOS supplementation protected DON-exposed mice by increasing the abundance of probiotics such as Bifidobacterium, Faecalibaculum, and Romboutsia. These gut microbes are known to enhance (P < 0.05) anti-inflammatory responses and the production of short-chain fatty acids (SCFAs), including total SCFAs, acetate, and valerate, compared with the DON group.

Conclusions

This study unveils that AOS not only enhances gut microbiota and intestinal barrier function but also significantly mitigates DON-induced intestinal damage.
背景:海藻酸寡糖(AOS)具有显著的抗炎、抗菌和抗氧化作用。脱氧雪腐镰刀菌烯醇(DON)有可能通过上调促炎细胞因子和细胞凋亡引发肠道炎症,从而损害肠道屏障功能的完整性并扰乱肠道微生物群的平衡:我们评估了 AOS 对减轻 DON 诱导的小鼠肠道损伤和全身炎症的影响:方法:经过一周的适应期后,小鼠被分为四组。三周内,AOS 组和 AOS + DON 组每天灌胃 200 μl AOS(200 毫克/千克体重),而 CON 组和 DON 组则灌胃等量的无菌磷酸盐缓冲盐水(PBS)。随后一周,DON 组和 AOS + DON 组每天摄入 100 μl DON(4.8 毫克/千克体重),而 CON 组和 AOS 组继续摄入 PBS:结果:通过灌胃给小鼠注射 DON 后,与对照(CON)组相比,小鼠体重显著下降(P < 0.05)。有趣的是,在 AOS + DON 组中,AOS 有减轻体重下降的趋势。在同时接受 AOS 和 DON 处理的小鼠粪便中,DON 的浓度比单独接受 DON 处理的组明显增加(P < 0.05)。组织学分析表明,DON 暴露导致肠道损伤加剧,包括绒毛缩短和上皮细胞被侵蚀。与 CON 组相比,在空肠和结肠组织中,DON 暴露显著降低了紧密连接蛋白(结肠中的 Claudin 和 Occludin)和粘蛋白 Mucin 2(MUC2)的表达(P < 0.05)。预防性服用 AOS 缓解了这些降低,从而改善了这些关键蛋白的表达水平。此外,补充 AOS 还能增加双歧杆菌、粪杆菌和 Romboutsia 等益生菌的数量,从而保护接触 DON 的小鼠。众所周知,与 DON 组相比,这些肠道微生物能增强(P < 0.05)抗炎反应和短链脂肪酸(SCFAs)的产生,包括总 SCFAs、乙酸盐和戊酸盐:本研究揭示了 AOS 不仅能增强肠道微生物群和肠道屏障功能,还能显著减轻 DON 引起的肠道损伤。
{"title":"Alginate Oligosaccharides Enhance Gut Microbiota and Intestinal Barrier Function, Alleviating Host Damage Induced by Deoxynivalenol in Mice","authors":"Jinqiu Mi ,&nbsp;Yaoyi Tong ,&nbsp;Qiyue Zhang ,&nbsp;Qingfeng Wang ,&nbsp;Yanwei Wang ,&nbsp;Yue Wang ,&nbsp;Gang Lin ,&nbsp;Qiugang Ma ,&nbsp;Tiantian Li ,&nbsp;Shimeng Huang","doi":"10.1016/j.tjnut.2024.09.031","DOIUrl":"10.1016/j.tjnut.2024.09.031","url":null,"abstract":"<div><h3>Background</h3><div>Alginate oligosaccharides (AOS) exhibits notable effects in terms of anti-inflammatory, antibacterial, and antioxidant properties. Deoxynivalenol (DON) has the potential to trigger intestinal inflammation by upregulating pro-inflammatory cytokines and apoptosis, thereby compromising the integrity of the intestinal barrier function and perturbing the balance of the gut microbiota.</div></div><div><h3>Objectives</h3><div>We assessed the impact of AOS on mitigating DON-induced intestinal damage and systemic inflammation in mice.</div></div><div><h3>Methods</h3><div>After a 1-wk acclimatization period, the mice were divided into 4 groups. For 3 wk, the AOS and AOS + DON groups were gavaged daily with 200 μL of AOS [200 mg/kg body weight (BW)], whereas the CON and DON groups received an equivalent volume of sterile Phosphate-Buffered Saline (PBS). Subsequently, for 1 wk, the DON and AOS + DON groups received 100 μL of DON (4.8 mg/kg BW) daily, whereas the control (CON) and AOS groups continued receiving PBS.</div></div><div><h3>Results</h3><div>After administering DON via gavage to mice, there was a significant decrease (<em>P</em> &lt; 0.05) in body weights compared with the CON group. Interestingly, AOS exhibited a tendency to mitigate this weight loss in the AOS + DON group. In the feces of mice treated with both AOS and DON, the concentration of DON significantly increased (<em>P</em> &lt; 0.05) compared with the DON group alone. Histological analysis revealed that DON exposure caused increased intestinal damage, including shortened villi and eroded epithelial cells, which was ameliorated by presupplementation with AOS, alleviating harm to the intestinal barrier function. In both jejunum and colon tissues, DON exposure significantly reduced (<em>P</em> &lt; 0.05) the expression of tight junction proteins (claudin and occludin in the colon) and the mucin protein mucin 2, compared with the CON group. Prophylactic administration of AOS alleviated these reductions, thereby improving the expression levels of these key proteins. Additionally, AOS supplementation protected DON-exposed mice by increasing the abundance of probiotics such as <em>Bifidobacterium</em>, <em>Faecalibaculum</em>, and <em>Romboutsia</em>. These gut microbes are known to enhance (<em>P</em> &lt; 0.05) anti-inflammatory responses and the production of short-chain fatty acids (SCFAs), including total SCFAs, acetate, and valerate, compared with the DON group.</div></div><div><h3>Conclusions</h3><div>This study unveils that AOS not only enhances gut microbiota and intestinal barrier function but also significantly mitigates DON-induced intestinal damage.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3190-3202"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substituting Potatoes with Other Food Groups and Type 2 Diabetes Risk: Findings from the Diet, Cancer, and Health Study. 用其他食物种类代替马铃薯与 2 型糖尿病风险:饮食、癌症与健康研究的结果。
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.10.040
Pratik Pokharel, Anja Olsen, Cecilie Kyrø, Anne Tjønneland, Kevin Murray, Lauren C Blekkenhorst, Marianne U Jakobsen, Christina C Dahm, Catherine P Bondonno, Jonathan M Hodgson, Nicola P Bondonno

Background: Although potatoes are considered a dietary staple in some cultures, evidence suggests that their impact on type 2 diabetes (T2D) risk is nuanced, with preparation methods and dietary patterns playing crucial roles. Investigating the substitution effects of replacing potatoes with other foods is required to inform dietary recommendations for lowering T2D risk.

Objective: The objective of this was to investigate associations between the substitution of potatoes (excluding fries/chips) with other food groups (vegetables, whole grains, refined grains, red meat, processed meat, poultry, fish, and dairy) and the risk of T2D.

Methods: The diet of participants from the prospective Danish Diet, Cancer, and Health study (DCH) was measured at baseline (1993-1997) by a food frequency questionnaire. Participants were followed up for incident T2D from baseline until 2012. Associations between the substitution of potatoes (total, boiled, and mashed) with other food groups and incident T2D was assessed by multivariable Cox proportional hazards model.

Results: In 54,793 DCH study participants, during a median follow-up of 16.3 y, 7693 incident T2D cases were recorded. A 26% lower risk of T2D was observed when 50 g/d of potatoes were substituted with the same amount of whole grains [hazard ratio and 95% confidence interval (CI): 0.74 (0.70, 0.79)]. Similarly, a lower risk of T2D was observed upon substituting 25 g/d of potatoes with an equivalent amount of green leafy [HR (95% CI): 0.79 (0.74, 0.83)], cruciferous [HR (95% CI): 0.87 (0.83, 0.92)], and yellow/orange/red vegetables [HR (95% CI): 0.97 (0.96, 0.99)]. Conversely, a higher risk of T2D was observed when potatoes were substituted with poultry [HR (95% CI): 1.08 (1.02, 1.15)], red meat [HR (95% CI): 1.06 (1.02, 1.10)], and processed meat [HR (95% CI): 1.17 (1.11, 1.23)]. Replacing boiled potatoes with red meat or poultry was associated with a higher risk of T2D compared with replacing mashed potatoes.

Conclusions: Substituting potatoes with whole grains and most types of vegetables was associated with a lower risk of T2D, whereas substituting potatoes with poultry, red meat, and processed meat was associated with a higher risk.

背景:虽然马铃薯在某些文化中被视为主食,但有证据表明,马铃薯对T2D风险的影响是微妙的,其制作方法和饮食模式起着至关重要的作用。需要调查用其他食物替代马铃薯的效果,以便为降低T2D风险的膳食建议提供信息:调查马铃薯(不包括薯条/薯片)与其他食物类别(蔬菜、全谷物、精制谷物、红肉、加工肉类、家禽、鱼类和乳制品)的替代效应与 T2D 风险之间的关系:丹麦饮食、癌症与健康前瞻性研究(DCH)的参与者在基线期(1993-1997 年)的饮食情况是通过食物频率问卷调查获得的。从基线到2012年,对参与者的T2D发病情况进行了随访。通过多变量考克斯比例危险模型评估了马铃薯(全马铃薯、煮马铃薯和捣碎的马铃薯)与其他食物组的替代情况与T2D发病率之间的关系:在 54,793 名大昌行研究参与者中,中位随访时间为 16.3 年,共记录了 7,693 例 T2D 发病病例。当每天用等量的全谷物代替 50 克马铃薯时,T2D 风险降低了 26%[HR 和 95% CI:0.74 (0.70, 0.79)]。同样,用等量的绿叶蔬菜[0.79 (0.74, 0.83)]、十字花科蔬菜[0.87 (0.83, 0.92)]和黄色/橙色/红色蔬菜[0.97 (0.96, 0.99)]代替每天 25 克马铃薯,也可观察到较低的 T2D 风险。相反,如果用家禽[1.08(1.02,1.15)]、红肉[1.06(1.02,1.10)]和加工肉类[1.17(1.11,1.23)]代替马铃薯,则患 T2D 的风险更高。用红肉或家禽代替水煮马铃薯比用马铃薯泥代替水煮马铃薯患 T2D 的风险更高:结论:用全谷物和大多数蔬菜代替马铃薯,患 T2D 的风险较低,而用家禽、红肉和加工肉类代替马铃薯,患 T2D 的风险较高。
{"title":"Substituting Potatoes with Other Food Groups and Type 2 Diabetes Risk: Findings from the Diet, Cancer, and Health Study.","authors":"Pratik Pokharel, Anja Olsen, Cecilie Kyrø, Anne Tjønneland, Kevin Murray, Lauren C Blekkenhorst, Marianne U Jakobsen, Christina C Dahm, Catherine P Bondonno, Jonathan M Hodgson, Nicola P Bondonno","doi":"10.1016/j.tjnut.2024.10.040","DOIUrl":"10.1016/j.tjnut.2024.10.040","url":null,"abstract":"<p><strong>Background: </strong>Although potatoes are considered a dietary staple in some cultures, evidence suggests that their impact on type 2 diabetes (T2D) risk is nuanced, with preparation methods and dietary patterns playing crucial roles. Investigating the substitution effects of replacing potatoes with other foods is required to inform dietary recommendations for lowering T2D risk.</p><p><strong>Objective: </strong>The objective of this was to investigate associations between the substitution of potatoes (excluding fries/chips) with other food groups (vegetables, whole grains, refined grains, red meat, processed meat, poultry, fish, and dairy) and the risk of T2D.</p><p><strong>Methods: </strong>The diet of participants from the prospective Danish Diet, Cancer, and Health study (DCH) was measured at baseline (1993-1997) by a food frequency questionnaire. Participants were followed up for incident T2D from baseline until 2012. Associations between the substitution of potatoes (total, boiled, and mashed) with other food groups and incident T2D was assessed by multivariable Cox proportional hazards model.</p><p><strong>Results: </strong>In 54,793 DCH study participants, during a median follow-up of 16.3 y, 7693 incident T2D cases were recorded. A 26% lower risk of T2D was observed when 50 g/d of potatoes were substituted with the same amount of whole grains [hazard ratio and 95% confidence interval (CI): 0.74 (0.70, 0.79)]. Similarly, a lower risk of T2D was observed upon substituting 25 g/d of potatoes with an equivalent amount of green leafy [HR (95% CI): 0.79 (0.74, 0.83)], cruciferous [HR (95% CI): 0.87 (0.83, 0.92)], and yellow/orange/red vegetables [HR (95% CI): 0.97 (0.96, 0.99)]. Conversely, a higher risk of T2D was observed when potatoes were substituted with poultry [HR (95% CI): 1.08 (1.02, 1.15)], red meat [HR (95% CI): 1.06 (1.02, 1.10)], and processed meat [HR (95% CI): 1.17 (1.11, 1.23)]. Replacing boiled potatoes with red meat or poultry was associated with a higher risk of T2D compared with replacing mashed potatoes.</p><p><strong>Conclusions: </strong>Substituting potatoes with whole grains and most types of vegetables was associated with a lower risk of T2D, whereas substituting potatoes with poultry, red meat, and processed meat was associated with a higher risk.</p>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
There Is No More Time Not To Consider the Planetary Diet for All 现在已经没有时间不考虑全民地球饮食了。
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.09.007
Alisson D Machado
{"title":"There Is No More Time Not To Consider the Planetary Diet for All","authors":"Alisson D Machado","doi":"10.1016/j.tjnut.2024.09.007","DOIUrl":"10.1016/j.tjnut.2024.09.007","url":null,"abstract":"","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3161-3162"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotaceuticals: Back to the future? 益生菌药物:回到未来?
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.09.006
Gordon S Howarth
Probiotic research has undergone some exciting and unanticipated changes in direction since the 2010 commentary by GSH, which speculated on probiotics being ultimately utilized as “factories” capable of releasing pharmaceutical-grade metabolites with therapeutic potential for a wide range of primarily gastrointestinal disorders. Indeed, the unrelenting search for new alternatives to antibiotics has further stimulated the development of “next-generation” probiotics. Postbiotics, defined as inanimate microorganisms and/or their components that confer a health benefit on the host, remain at the forefront of current probiotic research, with increasing numbers of probiotic species, strains, and substrains now being identified and further exploited as pharmabiotics; probiotics with a proven pharmacologic role in health and disease that have been subjected to clinical trial prior to approval by regulatory bodies. However, perhaps the most unanticipated probiotic development over the past 15 y has been the emergence of psychobiotics with the potential to improve aspects of mental health, such as depression and anxiety, through the release of bioactive metabolites. Moreover, the recent identification of pharmacobiotics, probiotics capable of facilitating the effectiveness of conventional pharmaceutical drugs, is opening new avenues for probiotic applications to combat a range of diseases, including cancers of the digestive system. Although in its infancy, recent reports of oncobiotics with antineoplastic properties are further expanding the potential for certain next-generation probiotics to impact current cancer treatment regimens and possibly even contribute to cancer prevention. Looking to the next 15 y of probiotic development, one could perhaps predict the ultimate development of regulatory-approved xenopostbiotic formulations comprising metabolites with the capacity to improve digestive health, decrease the severity of intestinal disease, and increase the effectiveness of conventional pharmaceuticals, whilst simultaneously improving cognitive functioning and mental welfare. Although speculative, these xenopostbiotic formulations could prove especially effective for the adjunctive treatment of serious chronic diseases such as cancer.
豪沃斯(Howarth)在 2010 年发表的评论文章中推测,益生菌最终将被用作 "工厂",能够释放出具有治疗潜力的药物级代谢物,主要用于治疗各种胃肠道疾病(1)。事实上,对抗生素新替代品的不懈探索进一步推动了 "新一代 "益生菌的发展。后益生菌被定义为对宿主健康有益的无生命微生物和/或其成分,它仍然是当前益生菌研究的前沿,越来越多的益生菌物种、菌株和亚菌株正在被鉴定并作为药用生物制剂进一步开发利用;这些益生菌在健康和疾病方面的药理作用已得到证实,并在获得监管机构批准之前经过了临床试验。然而,在过去的 15 年中,最出人意料的益生菌发展可能是精神生物的出现,它们通过释放生物活性代谢物,有可能改善抑郁和焦虑等心理健康问题。此外,最近还发现了药用生物,即能够促进传统药物疗效的益生菌,这为益生菌应用于防治包括消化系统癌症在内的一系列疾病开辟了新途径。尽管尚处于起步阶段,但最近关于具有抗肿瘤特性的肿瘤生物的报道进一步扩大了某些下一代益生菌影响当前癌症治疗方案的潜力,甚至可能有助于预防癌症。展望未来 15 年的益生菌发展,我们或许可以预测,最终会开发出监管部门批准的异种益生菌制剂,其中的代谢物具有改善消化系统健康、降低肠道疾病严重程度、提高传统药物疗效的能力,同时还能改善认知功能和精神健康。虽然只是推测,但这些异种生物制剂可能被证明对癌症等严重慢性疾病的辅助治疗特别有效。
{"title":"Probiotaceuticals: Back to the future?","authors":"Gordon S Howarth","doi":"10.1016/j.tjnut.2024.09.006","DOIUrl":"10.1016/j.tjnut.2024.09.006","url":null,"abstract":"<div><div>Probiotic research has undergone some exciting and unanticipated changes in direction since the 2010 commentary by GSH, which speculated on probiotics being ultimately utilized as “factories” capable of releasing pharmaceutical-grade metabolites with therapeutic potential for a wide range of primarily gastrointestinal disorders. Indeed, the unrelenting search for new alternatives to antibiotics has further stimulated the development of “next-generation” probiotics. <em>Postbiotics</em>, defined as inanimate microorganisms and/or their components that confer a health benefit on the host, remain at the forefront of current probiotic research, with increasing numbers of probiotic species, strains, and substrains now being identified and further exploited as <em>pharmabiotics</em>; probiotics with a proven pharmacologic role in health and disease that have been subjected to clinical trial prior to approval by regulatory bodies. However, perhaps the most unanticipated probiotic development over the past 15 y has been the emergence of <em>psychobiotics</em> with the potential to improve aspects of mental health, such as depression and anxiety, through the release of bioactive metabolites. Moreover, the recent identification of <em>pharmacobiotics</em>, probiotics capable of facilitating the effectiveness of conventional pharmaceutical drugs, is opening new avenues for probiotic applications to combat a range of diseases, including cancers of the digestive system. Although in its infancy, recent reports of <em>oncobiotics</em> with antineoplastic properties are further expanding the potential for certain next-generation probiotics to impact current cancer treatment regimens and possibly even contribute to cancer prevention. Looking to the next 15 y of probiotic development, one could perhaps predict the ultimate development of regulatory-approved <em>xenopostbiotic</em> formulations comprising metabolites with the capacity to improve digestive health, decrease the severity of intestinal disease, and increase the effectiveness of conventional pharmaceuticals, whilst simultaneously improving cognitive functioning and mental welfare. Although speculative, these xenopostbiotic formulations could prove especially effective for the adjunctive treatment of serious chronic diseases such as cancer.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3163-3166"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Dynamics of Methylation Concentrations in Glutathione Peroxidase 3 Promoter from Patients with Chronic Heart Failure and Their Association with Key Clinical Parameters 慢性心力衰竭患者 GPX3 Promoter 中甲基化水平的动态变化及其与主要临床参数的关系
IF 3.7 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2024-11-01 DOI: 10.1016/j.tjnut.2024.08.033
Yanmei Liu , Xu Zhao , Chuanyong Qu , Mengli Chen , Rongqiang Zhang

Objective

This study investigated changes in methylation concentrations within the glutathione peroxidase 3 (GPX3) promoter region among patients diagnosed with chronic heart failure (CHF). Peripheral blood samples were collected from 20 CHF patients and 20 healthy individuals for analysis.

Methods

Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, methylation concentrations of 11 CpG sites within the GPX3 promoter region were quantified.

Results

Results showed a significant increase in methylation at the GPX3_FA10_CpG_24 site in patients with CHF compared with the control group (P < 0.05). Furthermore, a nonlinear dose–response relationship was observed between methylation concentrations at this site and key clinical parameters including serum apolipoprotein A-1, D-dimer, chlorine, potassium, and sodium (Na) (P < 0.05).

Conclusions

These findings suggest that aberrant methylation of the GPX3 promoter may impact disease progression by influencing physiological functions such as blood lipids, coagulation, and electrolytes. Further investigations are warranted to elucidate the role of GPX3 promoter methylation in CHF pathogenesis, potentially contributing valuable insights for its prevention, diagnosis, and treatment.
研究目的本研究调查了慢性心力衰竭(CHF)患者谷胱甘肽过氧化物酶 3(GPX3)启动子区域甲基化水平的变化。研究收集了 20 名慢性心力衰竭患者和 20 名健康人的外周血样本进行分析:方法:使用基质辅助激光解吸电离飞行时间质谱对 GPX3 启动子区域内 11 个 CpG 位点的甲基化水平进行量化:结果发现,与对照组相比,CHF 患者 GPX3_FA10_CpG_24 位点的甲基化水平明显升高(P < 0.05)。此外,该位点的甲基化水平与血清载脂蛋白 A-1、D-二聚体、氯(Cl)、钾(K)和钠(Na)等主要临床指标之间存在非线性剂量反应关系(P < 0.05):这些研究结果表明,GPX3 启动子的异常甲基化可能会影响血脂、凝血和电解质等生理功能,从而影响疾病的进展。我们有必要进一步研究GPX3启动子甲基化在CHF发病机制中的作用,从而为CHF的预防、诊断和治疗提供有价值的见解。
{"title":"The Dynamics of Methylation Concentrations in Glutathione Peroxidase 3 Promoter from Patients with Chronic Heart Failure and Their Association with Key Clinical Parameters","authors":"Yanmei Liu ,&nbsp;Xu Zhao ,&nbsp;Chuanyong Qu ,&nbsp;Mengli Chen ,&nbsp;Rongqiang Zhang","doi":"10.1016/j.tjnut.2024.08.033","DOIUrl":"10.1016/j.tjnut.2024.08.033","url":null,"abstract":"<div><h3>Objective</h3><div>This study investigated changes in methylation concentrations within the glutathione peroxidase 3 (<em>GPX3</em>) promoter region among patients diagnosed with chronic heart failure (CHF). Peripheral blood samples were collected from 20 CHF patients and 20 healthy individuals for analysis.</div></div><div><h3>Methods</h3><div>Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, methylation concentrations of 11 CpG sites within the <em>GPX3</em> promoter region were quantified.</div></div><div><h3>Results</h3><div>Results showed a significant increase in methylation at the <em>GPX3</em>_FA10_CpG_24 site in patients with CHF compared with the control group (<em>P</em> &lt; 0.05). Furthermore, a nonlinear dose–response relationship was observed between methylation concentrations at this site and key clinical parameters including serum apolipoprotein A-1, D-dimer, chlorine, potassium, and sodium (Na) (<em>P</em> &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>These findings suggest that aberrant methylation of the <em>GPX3</em> promoter may impact disease progression by influencing physiological functions such as blood lipids, coagulation, and electrolytes. Further investigations are warranted to elucidate the role of <em>GPX3</em> promoter methylation in CHF pathogenesis, potentially contributing valuable insights for its prevention, diagnosis, and treatment.</div></div>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":"154 11","pages":"Pages 3365-3374"},"PeriodicalIF":3.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1